F-group (family)
3016.1.1.5 SHMT
Ligands and drugs
898
Member domains
331
with ligand contacts (≤ 4 Å)
36.9% of members
265
with DrugDomain annotations
29.5% of members
234
with a DrugBank compound
26.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3016.1.1.5 belongs to X-group 3016 C-terminal domain in some PLP-dependent transferases, which binds 8.0 ligand superclasses per 20 proteins, broader than 55% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02824 | PLG | N-Pyridoxyl-Glycine-5-Monophosphate | 103 |
| DB00145 | GLY | Glycine | 45 |
| DB11596 | FFO | Levoleucovorin | 22 |
| DB00133 | SER | Serine | 18 |
| DB03929 | DSN | D-Serine | 7 |
| DB00563 | MTX | Methotrexate | 6 |
| DB03256 | FON | (6R)-Folinic acid | 5 |
| DB00642 | LYA | Pemetrexed | 4 |
| DB02800 | THF | 5-hydroxymethyl-5,6-dihydrofolic acid | 3 |
| DB03345 | BME | Mercaptoethanol | 3 |
| DB03619 | DXC | Deoxycholic acid | 2 |
| DB11256 | THH | Levomefolic acid | 2 |
| DB12769 | DDF | Lometrexol | 2 |
| DB00114 | PLP | Pyridoxal phosphate | 1 |
| DB00116 | — | — | 1 |
| DB11638 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| PLG | N-GLYCINE-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YL-METHANE] | 120 |
| GLY | GLYCINE | 50 |
| FFO | N-[4-({[(6S)-2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid | 39 |
| SER | SERINE | 22 |
| PLS | [3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YLMETHYL]-SERINE | 19 |
| A1AQW | (E)-N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)glycine | 11 |
| CL | CHLORIDE ION | 11 |
| NAmetal | SODIUM ION | 10 |
| S8R | N-[4-({[(6R)-2-amino-5-formyl-4-hydroxy-5,6,7,8-tetrahydropteridin-6-yl]methyl}amino)benzoyl]-L-gamma-glutamyl-L-glutamic acid | 8 |
| DSN | D-SERINE | 7 |
| MTX | METHOTREXATE | 7 |
| PLP | PYRIDOXAL-5'-PHOSPHATE | 5 |
| ZVR | N-{4-[3-(2-amino-4-oxo-3,4-dihydro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)propyl]-2-fluorobenzoyl}-L-glutamic acid | 5 |
| 2BO | N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-L-threonine | 4 |
| 5M5 | (4R)-6-azanyl-4-[3-(hydroxymethyl)-5-phenyl-phenyl]-3-methyl-4-propan-2-yl-1H-pyrano[2,3-c]pyrazole-5-carbonitrile | 4 |
| Y72 | N-{4-[4-(2-amino-4-oxo-3,4-dihydro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)butyl]-3-fluorothiophene-2-carbonyl}-L-glutamic acid | 4 |
| 1W9 | (2R)-2-[(E)-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methylideneamino]-3-oxidanyl-propanoic acid | 3 |
| 33G | (4S)-6-amino-4-(5-cyano-3'-fluorobiphenyl-3-yl)-4-cyclobutyl-3-methyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | 3 |
| 8A0 | (4~{S})-6-azanyl-3-methyl-4-[3-(2-methylphenyl)-5-(trifluoromethyl)phenyl]-4-propan-2-yl-2~{H}-pyrano[2,3-c]pyrazole-5-carbonitrile | 3 |
| 8A3 | 4-[3-[(4~{S})-6-azanyl-5-cyano-3-methyl-4-propan-2-yl-2~{H}-pyrano[2,3-c]pyrazol-4-yl]-5-(trifluoromethyl)phenyl]-~{N}-methyl-~{N}-[2,2,2-tris(fluoranyl)ethyl]benzenesulfonamide | 3 |